This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Karan, D. Articles by Batra, S. K. Search for Related Content PubMed PubMed Citation Articles by Karan, D. Articles by Batra, S. K.

Decreased Androgen-responsive Growth of Human Prostate Cancer Is Associated with Increased Genetic Alterations¹

Department of Biochemistry and Molecular Biology [D. K., U. A. W., M-F. L., S. K. B.], and Eppley Institute for Research in Cancer and Allied Diseases [B. M. S., M-F. L., S. K. B.], Munroe-Meyer Institute, Human Genetics Laboratory, and Department of Pediatrics [B. J. D.], and Department of Surgery, Section of Urology [M-F. L.], University of Nebraska Medical Center, Omaha, Nebraska 68198, and Department of Visceral and Transplantation Surgery, Insel Hospital, Bern, Switzerland 3010 [B. M. S.]

Genetic mechanisms involved in prostate tumor progression from the androgen-responsive to androgen-unresponsive stage are not well understood because of the tremendous heterogeneity in the tumor as well as the lack of suitable models. Using 165 repeat microsatellite DNA markers distributed equally over all of the chromosomes, we determined an association between genetic alterations and androgen-unresponsive growth in three stages of LNCaP cell model (C33: early, androgen-responsive; C51: mid, decreased androgen-responsive; and C81: late, androgen-unresponsive and increased tumorigenicity). Furthermore, the genetic alterations were confirmed in laser microdissected normal and cancerous tissues from 15 clinical samples of human prostatic adenocarcinomas using selected markers. A stem-line karyotype analysis exhibited an identical chromosomal pattern in both C33 and C81 stage cells except for the structural rearrangements of chromosome 3 and a gain of one copy of the Y chromosome in the androgen-unresponsive C81 stage cells. Nine microsatellite DNA markers on seven different chromosomes (1, 4, 5, 11, 17, 18, and 19) showed microsatellite instability (MSI) in both C51 and C81 stage cells. Additionally, 23 markers on 15 different chromosomes revealed MSI in C81 cells. Chromosomal regions demonstrating allelic loss (AL) include 1q, 3p, 5p, 8q, 9q, and 13q in C51 and C81 cells. In clinical human specimens, MSI was observed on chromosomes 1 (20%), 5 (23%), 17 (40%), and 19 (36%), whereas ALs were found 40% on chromosomal region 1q, 20% on 3p, 26% on 5p and 8q, and 33% on 13q. In conclusion, the LNCaP cell model showed the increasing number of genetic changes including MSI and AL. These increased genetic alterations may be associated with the development of the androgen-unresponsive phenotype.

This article has been cited by other articles:

				Y.-A. Kim, D. Xiao, H. Xiao, A. A. Powolny, K. L. Lew, M. L. Reilly, Y. Zeng, Z. Wang, and S. V. Singh Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak Mol. Cancer Ther., May 1, 2007; 6(5): 1599 - 1609. [Abstract] [Full Text] [PDF]

				S. Mitra, L. Annamalai, S. Chakraborty, K. Johnson, X.-H. Song, S. K. Batra, and P. P. Mehta Androgen-regulated Formation and Degradation of Gap Junctions in Androgen-responsive Human Prostate Cancer Cells Mol. Biol. Cell, December 1, 2006; 17(12): 5400 - 5416. [Abstract] [Full Text] [PDF]

				T.-C. Yuan, S. Veeramani, F.-F. Lin, D. Kondrikou, S. Zelivianski, T. Igawa, D. Karan, S. K. Batra, and M.-F. Lin Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocr. Relat. Cancer, March 1, 2006; 13(1): 151 - 167. [Abstract] [Full Text] [PDF]

				A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower, and N. J. Maitland Prospective Identification of Tumorigenic Prostate Cancer Stem Cells Cancer Res., December 1, 2005; 65(23): 10946 - 10951. [Abstract] [Full Text] [PDF]

				B. S. Schaffer, M.-F. Lin, J. C. Byrd, J. H. Y. Park, and R. G. MacDonald Opposing Roles for the Insulin-Like Growth Factor (IGF)-II and Mannose 6-Phosphate (Man-6-P) Binding Activities of the IGF-II/Man-6-P Receptor in the Growth of Prostate Cancer Cells Endocrinology, March 1, 2003; 144(3): 955 - 966. [Abstract] [Full Text] [PDF]

				D. Karan, D. L. Kelly, A. Rizzino, M.-F. Lin, and S. K. Batra Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells Carcinogenesis, June 1, 2002; 23(6): 967 - 976. [Abstract] [Full Text] [PDF]